Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 524,078 |
|
|||||
| News | (1) | ||||||
| Day High | 15.85 | Low High |
|||||
| Day Low | 14.71 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Arcus Biosciences Inc | RCUS | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.07 | -0.45% | 15.43 | 18:12:18 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 15.49 | 14.71 | 15.85 | 15.43 | 15.50 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,459 | 524,078 | $ 15.24 | $ 7,984,418 | - | 12.95 - 25.47 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:30:00 | 107,896 | $ 15.43 | USD |
Arcus Biosciences (RCUS) Options Flow Summary
Arcus Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.4B | 90.86M | - | 117M | -307M | -3.38 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Arcus Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RCUS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.95 | 16.04 | 14.10 | 14.89 | 665,919 | -0.52 | -3.26% |
| 1 Month | 16.90 | 19.11 | 14.10 | 16.73 | 581,325 | -1.47 | -8.70% |
| 3 Months | 15.70 | 20.31 | 14.10 | 17.40 | 818,623 | -0.27 | -1.72% |
| 6 Months | 16.33 | 20.31 | 12.95 | 16.82 | 803,834 | -0.90 | -5.51% |
| 1 Year | 19.82 | 25.47 | 12.95 | 18.39 | 870,044 | -4.39 | -22.15% |
| 3 Years | 35.88 | 49.10 | 12.95 | 24.45 | 853,653 | -20.45 | -57.00% |
| 5 Years | 11.08 | 49.10 | 6.30 | 24.23 | 681,684 | 4.35 | 39.26% |
Arcus Biosciences Description
| Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies. |
